1 / 10

China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024

For more Info:<br><br>https://www.renub.com/china-anti-cancer-drugs-market-nd.php<br><br>In China, cancer is a major public health concern. Several factors are responsible for the increasing prevalence of cancer in China such as extensive use of tobacco, unhealthy lifestyle and rising geriatric population. Almost one-third of the world’s lung cancer and nearly half of the liver, stomach and esophageal cases of cancer occur in China. China Cancer Drugs Market is expected to be US$ 30 Billion by the year 2024. <br> <br>Cancer drugs act at various levels – cancer cells, extracellular matrix, endothelium, host cells or immune system. The cancerous cell can be targeted at the DNA, RNA or protein level. Most available chemotherapy drugs interact with tumor DNA while targeted drugs (monoclonal antibodies) and small molecules directed against proteins. With increasing incidence of cancer cases in China, rising per capita income in the region, growing awareness regarding cancer coupled with improving healthcare infrastructure and reimbursement on cancer drugs, it is believed that China Cancer Drugs Market will certainly touch new leap in the forthcoming years. <br> <br>Request a free sample copy of the report: <br><br>https://www.renub.com/contactus.php<br> <br>The decision of using a cancer drug depends on several factors, including the type of cancer and the location of the cancer and its stage. Generally cancer drugs are administered intravenously; however, some cancer medicines can also be taken orally and others can be administered intramuscularly or intrathecally (within the spinal cord). The treatment of cancer is very intricate, the cancer drugs used to treat cancer cell, sometimes target normal cells, though cells that have undergone genetic changes and are dividing at a fast and uncontrolled rate. Apparently, there are certain anticancer drugs which can differentiate between healthy cells and the cancer cells. <br>

renubresearch
Download Presentation

China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category: Drugs & Pharmaceuticals Market Report

  2. China Anti Cancer Drugs Market Analyst View: • China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. GetFree Customization in this Report • Press Release Title: • China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. • For more Info:  • https://www.renub.com/china-anti-cancer-drugs-market-nd.php

  3. China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. • Research Report Title: • China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma) • Access Full Research:  • https://www.renub.com/china-cancer-drugs-market-p.php • In China, cancer is a major public health concern. Several factors are responsible for the increasing prevalence of cancer in China such as extensive use of tobacco, unhealthy lifestyle and rising geriatric population. Almost one-third of the world’s lung cancer and nearly half of the liver, stomach and esophageal cases of cancer occur in China. 

  4. China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. China Cancer Drugs Market is expected to be US$ 30 Billion by the year 2024. Cancer drugs act at various levels – cancer cells, extracellular matrix, endothelium, host cells or immune system. The cancerous cell can be targeted at the DNA, RNA or protein level. Most available chemotherapy drugs interact with tumor DNA while targeted drugs (monoclonal antibodies) and small molecules directed against proteins. With increasing incidence of cancer cases in China, rising per capita income in the region, growing awareness regarding cancer coupled with improving healthcare infrastructure and reimbursement on cancer drugs, it is believed that China Cancer Drugs Market will certainly touch new leap in the forthcoming years.  Request a free sample copy of the report:  https://www.renub.com/contactus.php The decision of using a cancer drug depends on several factors, including the type of cancer and the location of the cancer and its stage. Generally cancer drugs are administered intravenously; however, some cancer medicines can also be taken orally and others can be administered intramuscularly or intrathecally

  5. China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024.

  6. China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. With the advancement in medicinal technology, in the early 21st century, the identification of molecular features unique to cancer cells stimulated the evolution of targeted cancer therapies, which possess a pretty high degree of specificity for cancer cells. Today, across the globe, targeted therapy for cancer treatment is gaining popularity because targeted therapy are designed to block the growth and spread of cancer by interfering with a specific biochemical pathway central to the development, growth, and spread of that particular cancer unlike chemotherapy that act on all rapidly dividing normal and cancerous cells. Chinese biopharmaceuticals industry is witnessing a rapid transformation as the government focuses on an innovation-driven economic by 2020. In the last two decades, China has invested a total of 18% of the world’s spending on Research and Development (R&D) across all sectors. Healthcare sector has a specific precedence, as the Chinese government facing dual challenges of improving the health of the population and maintaining the growth of the biopharmaceutical industry. Recently, the government has stepped up its efforts in reducing the cost of cancer drugs and has eliminated import tariffs on almost all cancer drugs, so that the Chinese patients need not have to give up their treatment. These recent developments will certainly drive China Cancer Drugs Market in near future. 

  7. China Anti Cancer Drugs Market expected to be US$ 30 Billion by 2024. • Client can Purchase this Report in Sections from below link:  • Access full Research: https://www.renub.com/china-cancer-drugs-market-p.php • China Anti Cancer Drugs Market Summary • On the basis of drugs type Cytotoxic Drugs controls the Anti Cancer Drugs Market in China. The report is further segmented into Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, TCM and Others. Cytotoxic Drugs is further divided into Antimetabolites, Plant Alkaloids and Alkylating Agents.   • Based on Cancer types, Lung cancer drives the China Anti Cancer Drugs Market. The other cancer markets studied in the report are as follows: Lung, Stomach, Breast, Esophageal, Liver & Others.   • On the basis of Therapy type, China Anti Cancer Drugs Market is divided into following segments Chemotherapy, Targeted Therapy, Hormonal Therapy and Others. • Companies studied in the report are as follows: Merck, Celegene, Eli Lilly, Roche, Sino & BioPharma • If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at  • info@renub.com

  8. Table of Contents for China Anti Cancer Drugs Market Key Topics Covered 1. Executive Summary 2.    China Cancer Drugs Market 3.    Market Share – China Anti-Cancer Drugs 3.1    By Drugs 3.2    By Cancer3.3    By Therapy 4.    Drugs – China Cancer Market 4.1    Cytotoxic Drugs 4.2    Targeted Drugs4.3    Monoclonal Antibiotics 4.4    Hormonal Drugs4.5    Traditional Chinese Medicine 4.6    Others 5.    Cancer Type – Market 5.1    Lung Cancer 5.2    Stomach Cancer5.3    Breast Cancer 5.4    Esophageal Cancer5.5    Liver Cancer 5.6    Others

  9. Table of Contents for China Anti Cancer Drugs Market 6.    Therapy – China Cancer Market 6.1    Chemotherapy 6.2    Targeted Therapy6.3    Hormonal Therapy 6.4    Others 7.    Company Analysis 7.1    Merck 7.2    Celgene 7.3    Eli Lilly 7.4    Roche 7.5    Sino BioPharma 8.    Growth Drivers 8.1    Growing Awareness towards Cancer Diagnosis and Treatment8.2    Increasing Use of Targeted Therapy8.3    Increasing Research and Development Activities8.4    Cutting Import Duties on Cancer Drugs 9.    Challenges 9.1    High Cost of Cancer Drugs9.2    Major Side Effects of Cancer Treatment

  10. GetFree Customization in this Report • Drugs & Pharmaceuticals Market Reports: • https://www.renub.com/drugs-and-pharmaceuticals-13-c.php

More Related